Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,402.00
+5.10 (0.37%)
Nov 4, 2026, 3:29 PM IST
Cipla Employees
Cipla had 31,369 employees as of March 31, 2026. The number of employees increased by 1,056 or 3.48% compared to the previous year. That makes Cipla the 1,175th largest employer in the world and 63rd in India.
Employees
31,369
Change (1Y)
1,056
Growth (1Y)
3.48%
Revenue / Employee
8.92M INR
Profits / Employee
923.53K INR
Market Cap
1.13T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 31,369 | 1,056 | 3.48% |
| Mar 31, 2025 | 30,313 | 2,549 | 9.18% |
| Mar 31, 2024 | 27,764 | -4,559 | -14.10% |
| Mar 31, 2023 | 32,323 | 6,396 | 24.67% |
| Mar 31, 2022 | 25,927 | 255 | 0.99% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zydus Lifesciences | 29,980 |
| Aurobindo Pharma | 29,209 |
| Mankind Pharma | 20,451 |
| Alkem Laboratories | 19,346 |
| Ipca Laboratories | 17,210 |
| Glenmark Pharmaceuticals | 16,946 |
| Divi's Laboratories | 11,565 |
| Ajanta Pharma | 10,421 |
Cipla News
- 8 days ago - Cipla Transcript: Q2 26/27 - Transcripts
- 8 days ago - Cipla Quarterly report: Q2 2027 - Filings
- 8 days ago - Cipla Slides: Q2 2027 - Filings
- 8 days ago - India's Cipla misses quarterly profit view on muted US sales - Reuters
- 20 days ago - Indoco Remedies Share Price Quietly Does Something Most Mid-Cap Pharma Stocks Won’t - ABC Money
- 4 weeks ago - FDA cancels Pune Cipla facility's drug sale and distribution licences - The Times of India
- 4 weeks ago - Cipla's Pune Godown Loses Drug Licence Over 'Misbranding, Storage Violations' - NDTV
- 2 months ago - India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar - Reuters